WorldUpstart Accelerator Industry Day
Join industry executives and leading Digital Health, Medical Devices and Pharma companies entering the US Market from Australia, France, Germany, Japan, and South Korea.
Connect with decision-makers bringing new innovations to the healthcare market and enjoy spectacular views of Philadelphia from the 50th floor of One Liberty Place.
Bonus: Join for a Complimentary Cocktail Hour and get a sneak peak of the new Quartermaster Science + Technology Park from 4 - 5:30 pm. Free shuttle picks up and returns to One Liberty Place
Digital Health
Deeplink Medical (France) offers award-winning software to improve imaging and data workflows in oncology and radiology. ITIS and MIRIO are platforms used by 34,000 healthcare professionals, and the company has received $16 million from the French medical establishment to fund its growth.
Medmain’s (Japan) AI-driven image analysis software is tackling the worldwide shortage of cancer diagnoses and treatment plans. PitPort combines online pathological diagnosis and AI deep learning to provide highly accurate and rapidly analyzed medical results. Medmain is on a mission to make medical services available wherever technology is.
Previa Medical (France) reduces the risk of complications in healthcare settings. Certified in 2021, its AI-based platform SEPSI-SCORE provides early detection of sepsis, which is the leading cause of death in US hospitals. Previa Medical’s technology identifies treatment gaps before symptoms present, leading to better patient outcomes and cost savings.
StrongRoom AI (Australia) is an AI-driven controlled drugs management platform aimed at reducing adverse drug events within pharmacy, hospital, and aged care facility settings. With more than 2,000 customers across Australia, the EU, Japan, and the UK, StrongRoom AI now plans to replicate its success in the US market.
Pharma
Cartago Biotech (Australia) is developing a recombinant biologic to regenerate a patient’s spinal intervertebral disc. CBT005 repairs and regenerates damaged disks, relieves pain, and promotes increased mobility, which could become the standard of care for refractory disc degeneration and chronic back pain.
ViMREX (Germany) is running a multi-center clinical phase I trial with patients for a topical drug product against anogenital HPV-induced precancerous lesions. It contains a demethylating agent and is designed to be causally effective, tissue-conserving, and can be self-administered by patients.
Medical Devices
Benilight (South Korea) developed a flexible infrared light therapy pad for photobiomodulation (PBM) to accelerate healthy cell generation and provide non-invasive pain relief. Having gained traction in Asia and Australia, Benilight is now pursuing FDA approval to bring its iLED Pro into more homes and healthcare facilities.
IndieNov (France) designs and manufactures medical devices with integrated electronics and AI to extend independent living for seniors. IndieNov’s belt is a lightweight 3-in-1 solution that prevents falls and sends instant medical alerts. Its mobility scoring predicts femoral neck fractures using data collected from belt users.
Lattice Medical (France) produces a breakthrough bioabsorbable and tissue engineered implant for breast reconstruction and augmentation. Lattice’s own 3D medical device printer creates a personalized shell that is reabsorbed by the body while helping autologous fat tissues to regenerate, avoiding more surgeries and significantly reducing patient risks.
MexBrain (France) uses dialysis and nanotechnology to efficiently extract metals from the bloodstream. One in five ICU patients has excess metals, which can impact organ function resulting in death if untreated. The MEX-CD1 received clinical trial authorization for use on Wilson’s disease patients and will add clinical trials for ACLF, sepsis, and AKI.
Sponsored by WorldUpstart, Quartermaster Science & Technology Park, and DLA Piper.